AAAAAA
Results: 1-25/113
Authors:
CAMPO E
GAULARD P
ZUCCA E
JAFFE ES
HARRIS NL
DIEBOLD J
SCHLEGELBERGER B
FELLER AC
DELSOL C
GISSELBRECHT C
MONTSERRAT E
Citation: E. Campo et al., REPORT OF THE EUROPEAN TASK-FORCE ON LYMPHOMAS - WORKSHOP ON PERIPHERAL T-CELL LYMPHOMAS, Annals of oncology, 9(8), 1998, pp. 835-843
Authors:
HAIOUN C
LEPAGE E
GISSELBRECHT C
COIFFIER B
DOYEN C
MOREL P
ATTAL M
TILLY H
DECONINCK E
GAULARD P
REYES F
Citation: C. Haioun et al., HIGH-DOSE THERAPY FOLLOWED BY STEM-CELL TRANSPLANTATION IN PARTIAL-RESPONSE AFTER FIRST-LINE INDUCTION THERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA, Annals of oncology, 9, 1998, pp. 5-8
Authors:
MOUNIER N
GISSELBRECHT C
Citation: N. Mounier et C. Gisselbrecht, CONDITIONING REGIMENS BEFORE TRANSPLANTATION IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA, Annals of oncology, 9, 1998, pp. 15-21
Authors:
BRICE P
CAZALS D
MOUNIER N
VEROLA O
NEIDHARTBERARD AM
REMENIERAS L
DECONINCK E
DOYEN C
HAMELSAND J
MOLINA T
MOULONGUET I
GISSELBRECHT C
Citation: P. Brice et al., PRIMARY CUTANEOUS LARGE-CELL LYMPHOMA - ANALYSIS OF 49 PATIENTS INCLUDED IN THE LNH87 PROSPECTIVE TRIAL OF POLYCHEMOTHERAPY FOR HIGH-GRADE LYMPHOMAS, Leukemia, 12(2), 1998, pp. 213-219
Authors:
COLE BF
SOLALCELIGNY P
GELBER RD
LEPAGE E
GISSELBRECHT C
REYES F
SEBBAN C
SUGANO D
TENDLER C
GOLDHIRSCH A
Citation: Bf. Cole et al., QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING, Journal of clinical oncology, 16(7), 1998, pp. 2339-2344
Authors:
LUNDIN J
OSTERBORG A
BRITTINGER G
CROWTHER D
DOMBRET H
ENGERT A
EPENETOS A
GISSELBRECHT C
HUHN D
JAEGER U
THOMAS J
MARCUS R
NISSEN N
POYNTON C
RANKIN E
STAHEL R
UPPENKAMP M
WILLEMZE R
MELLSTEDT H
Citation: J. Lundin et al., CAMPATH-1H MONOCLONAL-ANTIBODY IN THERAPY FOR PREVIOUSLY TREATED LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II MULTICENTER STUDY, Journal of clinical oncology, 16(10), 1998, pp. 3257-3263
Authors:
GUGLIELMI C
GOMEZ F
PHILIP T
HAGENBEEK A
MARTELLI M
SEBBAN C
MILPIED N
BRON D
CAHN JY
SOMERS R
SONNEVELD P
GISSELBRECHT C
VANDERLELIE H
CHAUVIN F
Citation: C. Guglielmi et al., TIME TO RELAPSE HAS PROGNOSTIC VALUE IN PATIENTS WITH AGGRESSIVE LYMPHOMA ENROLLED ONTO THE PARMA TRIAL, Journal of clinical oncology, 16(10), 1998, pp. 3264-3269
Authors:
MOREAU P
FLEURY J
BRICE P
COLOMBAT P
BOUABDALLAH R
LIOURE B
VOILLAT L
CASASNOVAS O
FRANCOIS S
SADOUN A
LAMY T
LOTZ JP
MUNCK JN
DIVINE M
FERME C
PENY AM
FRUCHART C
ORIOL P
OJEDA M
REMAN O
MILPIED N
GISSELBRECHT C
LEGROS M
HAROUSSEAU JL
Citation: P. Moreau et al., EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN ADVANCED HODGKINS-DISEASE - RETROSPECTIVE ANALYSIS OF 158 CASES FROM THE FRENCH REGISTRY, Bone marrow transplantation, 21(8), 1998, pp. 787-793
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
FERRANT A
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
GISSELBRECHT C
COIFFIER B
Citation: A. Bosly et al., SUPERIORITY OF LATE OVER EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH RP-93/, Bone marrow transplantation, 21, 1998, pp. 585-585
Authors:
SIMON D
HAIOUN C
GAULARD P
SALLES G
TILLY H
BOSLY A
DIEBOLD J
GISSELBRECHT C
Citation: D. Simon et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PTCL, Bone marrow transplantation, 21, 1998, pp. 593-593
Authors:
PHILIP T
GOMEZ F
GUGLIELMI C
HAGENBEEK A
SEBBAN C
MILPIED N
BRON D
CAHN JY
SOMERS R
SONNEVELD P
GISSELBRECHT C
VANDERLELIE H
CHAUVIN F
Citation: T. Philip et al., LONG-TERM OUTCOME OF RELAPSED NON-HODGKINS-LYMPHOMA (NHL) PATIENTS INCLUDED IN THE PARMA TRIAL - INCIDENCE OF LATE RELAPSES, LONG-TERM TOXICITY AND IMPACT OF THE INTERNATIONAL PROGNOSTIC INDEX (IPI) AT RELAPSE, Bone marrow transplantation, 21, 1998, pp. 595-595
Authors:
MILPIED N
ATTAL M
GISSELBRECHT C
MARIT G
TANGUY ML
PICO JL
IFRAH N
Citation: N. Milpied et al., LYMPHOBLASTIC LYMPHOMA (LBL) - WHAT IS THE BEST TIME FOR TRANSPLANTATION (BMT) - A STUDY FROM SFGM, Bone marrow transplantation, 21, 1998, pp. 597-597
Authors:
HAIOUN C
LEPAGE E
GISSELBRECHT C
COIFFIER B
DOYEN C
MOREL P
ARTAL M
TILLY H
DECONINCK E
GAULARD P
REYES F
Citation: C. Haioun et al., AUTOLOGOUS TRANSPLANTATION VERSUS CONVENTIONAL SALVAGE THERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) PARTIALLY RESPONDING TO FIRST LINECHEMOTHERAPY - A STUDY OF 94 PATIENTS ENROLLED IN THE LNH87-2 PROTOCOL, Bone marrow transplantation, 21, 1998, pp. 599-599
Authors:
HAIOUN C
GISSELBRECHT C
QUESNEL B
MOREL P
REYES F
Citation: C. Haioun et al., DOUBLE AUTOTRANSPLANT (DAT) AS FIRST LINE CONSOLIDATIVE TREATMENT IN POOR-RISK AGGRESSIVE LYMPHOMA - A PILOT-STUDY OF 31 PATIENTS, Bone marrow transplantation, 21, 1998, pp. 600-600
Authors:
GUGLIELMI C
GOMEZ F
HAGENBEEK A
SEBBAN C
MARTELLI M
MILPIED N
BRON D
CAHN JY
SOMERS R
SONNEVELD P
GISSELBRECHT C
VANDERLELIE H
CHAUVIN F
PHILIP T
Citation: C. Guglielmi et al., TIME TO RELAPSE HAS PROGNOSTIC VALUE IN AGGRESSIVE LYMPHOMA ENROLLED IN THE PARMA TRIAL AT FIRST RELAPSE, Bone marrow transplantation, 21, 1998, pp. 623-623
Authors:
MOUNIER N
GISSELBRECHT C
LEPAGE E
Citation: N. Mounier et al., TREATMENT OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA, The New England journal of medicine, 339(20), 1998, pp. 1476-1476
Authors:
MOUNIER N
MOREL P
HAIOUN C
COIFFIER B
TILLY H
CHATELAIN C
LEDERLIN P
THYSS A
HERBRECHT R
GISSELBRECHT C
LEPAGE E
Citation: N. Mounier et al., A MULTIVARIATE-ANALYSIS OF THE SURVIVAL OF PATIENTS WITH AGGRESSIVE LYMPHOMA - VARIATIONS IN THE PREDICTIVE VALUE OF PROGNOSTIC FACTORS DURING THE COURSE OF THE DISEASE, Cancer, 82(10), 1998, pp. 1952-1962
Authors:
SIMON D
GISSELBRECHT C
SEBBAN C
REYES F
BOSLY A
GABARRE J
MOREL P
BOULAT O
LEPAGE E
Citation: D. Simon et al., SYSTEM OF THERAPEUTIC DECISION-MAKING FOR G-CSF PRESCRIPTION IN AGGRESSIVE NON-HODGKIN LYMPHOMAS, British Journal of Haematology, 102(1), 1998, pp. 90-90
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
FERRANT A
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
GISSELBRECHT C
COIFFIER B
Citation: A. Bosly et al., SUPERIORITY OF LATE OVER EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH-RP-93/, British Journal of Haematology, 102(1), 1998, pp. 148-148
Authors:
FORAN JM
ROHATINER AZS
CUNNINGHAM D
POPESCU R
SOLAICELIGNY P
CAVALLI F
COIFFIER B
JOHNSON P
GISSELBRECHT C
HAIOUN C
BESSELL E
SWEETENHAM J
RADFORD J
BENZOHRA A
LISTER TA
Citation: Jm. Foran et al., IMMUNOTHERAPY OF MANTLE CELL LYMPHOMA (MCL), LYMPHOPLASMACYTOID LYMPHOMA (LPC) AND WALDENSTROMS MACROGLOBULINEMIA (WM), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL) WITH RITUXIMAB (IDEC-C288) - PRELIMINARY-RESULTS OF AN ONGOING INTERNATIONAL MULTICENTER TRIAL, British Journal of Haematology, 102(1), 1998, pp. 149-149
Authors:
LANGOUET AM
SIMON D
BRICE P
REYES F
SALLES G
TILLY H
FARINOTTI R
FAURE P
LEPAGE E
GISSELBRECHT C
Citation: Am. Langouet et al., FACTORS INFLUENCING HEMATOLOGIC RECOVERY AFTER PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN AGGRESSIVE NON-HODGKINS-LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 206-206
Authors:
ANDRE M
HENRYAMAR M
BLAISE D
COLOMBAT P
FLEURY J
MILPIED N
CAHN JY
PICO JL
BASTION Y
KUENTZ M
NEDELLEC G
ATTAL M
FERME C
GISSELBRECHT C
Citation: M. Andre et al., TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE, Blood, 92(6), 1998, pp. 1933-1940
Authors:
GISSELBRECHT C
GAULARD P
LEPAGE E
COIFFIER B
BRIERE J
HAIOUN C
CAZALSHATEM D
BOSLY A
XERRI L
TILLY H
BERGER F
BOUHABDALLAH R
DIEBOLD J
Citation: C. Gisselbrecht et al., PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS, Blood, 92(1), 1998, pp. 76-82
Authors:
ANDRE M
BRICE P
CAZALS D
HENNEQUIN C
FERME C
KERNEIS Y
ROUSSELOT P
ZINI JM
LEPAGE E
GISSELBRECHT C
Citation: M. Andre et al., RESULTS OF 3 COURSES OF ADRIAMYCIN, BLEOMYCIN, VINDESINE, AND DACARBAZINE WITH SUBTOTAL NODAL IRRADIATION IN 189 PATIENTS WITH NODAL HODGKINS-DISEASE (STAGE-I, STAGE-II AND STAGE-IIIA), HEM CELL TH, 39(2), 1997, pp. 59-65
Authors:
MARIN GH
DALCORTIVO L
CAYUELA JM
MAROLLEAU JP
PAUTIER P
COJEANZELEK I
BRICE P
MAKKE J
BENBUNAN M
GISSELBRECHT C
Citation: Gh. Marin et al., PERIPHERAL-BLOOD STEM-CELL CD34+ AUTOLOGOUS TRANSPLANT IN RELAPSED FOLLICULAR LYMPHOMA, HEM CELL TH, 39(1), 1997, pp. 33-40